SE0301936D0 - New polypeptide - Google Patents

New polypeptide

Info

Publication number
SE0301936D0
SE0301936D0 SE0301936A SE0301936A SE0301936D0 SE 0301936 D0 SE0301936 D0 SE 0301936D0 SE 0301936 A SE0301936 A SE 0301936A SE 0301936 A SE0301936 A SE 0301936A SE 0301936 D0 SE0301936 D0 SE 0301936D0
Authority
SE
Sweden
Prior art keywords
polypeptide
sample
insulin
nucleic acid
sequence
Prior art date
Application number
SE0301936A
Other languages
English (en)
Inventor
Joachim Feldwisch
Elin Gunneriusson
Per-Aake Nygren
Original Assignee
Affibody Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affibody Ab filed Critical Affibody Ab
Priority to SE0301936A priority Critical patent/SE0301936D0/sv
Publication of SE0301936D0 publication Critical patent/SE0301936D0/sv
Priority to PCT/SE2004/001050 priority patent/WO2005000883A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/20—Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region or antibody mimetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE0301936A 2003-06-30 2003-06-30 New polypeptide SE0301936D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0301936A SE0301936D0 (sv) 2003-06-30 2003-06-30 New polypeptide
PCT/SE2004/001050 WO2005000883A1 (en) 2003-06-30 2004-06-30 Polypeptides having binding affinity for insulin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301936A SE0301936D0 (sv) 2003-06-30 2003-06-30 New polypeptide

Publications (1)

Publication Number Publication Date
SE0301936D0 true SE0301936D0 (sv) 2003-06-30

Family

ID=27731066

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301936A SE0301936D0 (sv) 2003-06-30 2003-06-30 New polypeptide

Country Status (2)

Country Link
SE (1) SE0301936D0 (sv)
WO (1) WO2005000883A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0524788D0 (en) 2005-12-05 2006-01-11 Affibody Ab Polypeptides
US8426557B2 (en) 2007-08-03 2013-04-23 Affibody Ab IGF-1R binding polypeptides and their use
GB0805608D0 (en) * 2008-03-28 2008-04-30 Sec Dep For Environment Food & Detection method
US20120165650A1 (en) 2010-12-22 2012-06-28 General Electric Company Her2 binders
US20110171124A1 (en) 2009-02-26 2011-07-14 Osi Pharmaceuticals, Inc. In situ methods for monitoring the EMT status of tumor cells in vivo
WO2014013016A1 (en) 2012-07-20 2014-01-23 Affibody Ab Method for determining the her2 status of a malignancy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462046C (sv) * 1982-08-23 1998-04-27 Pharmacia Biotech Ab Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma
WO1992009633A1 (en) * 1990-11-26 1992-06-11 Public Health Laboratory Service Board Immunoglobulin-binding proteins and recombinant dna molecules coding therefor
US6013763A (en) * 1996-06-04 2000-01-11 Genentech, Inc. Peptide variants of protein A
GB9823071D0 (en) * 1998-10-21 1998-12-16 Affibody Technology Ab A method
SE9901379D0 (sv) * 1999-04-19 1999-04-19 Pharmacia & Upjohn Ab Receptor structures
AU2001234125A1 (en) * 2000-02-22 2001-09-03 Medical And Biological Laboratories Co., Ltd. Antibody library
AU2001262750A1 (en) * 2000-06-14 2001-12-24 Medical And Biological Laboratories Co., Ltd. Method of constructing scfv antibody fused with fluorescent protein
GB0017720D0 (en) * 2000-07-19 2000-09-06 Got A Gene Ab Modified virus
SE0200943D0 (sv) * 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein

Also Published As

Publication number Publication date
WO2005000883A8 (en) 2005-03-03
WO2005000883A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
SE0400274D0 (sv) New polypeptide
Rabilloud Membrane proteins and proteomics: love is possible, but so difficult
DE602006018592D1 (de) Tnf-alhpa-bindendes polypeptid, anwendungen davon und verfahren, bei denen dieses verwendet wird
Pedersen et al. Unseen proteome: mining below the tip of the iceberg to find low abundance and membrane proteins
Rucker et al. Host‐guest scale of left‐handed polyproline II helix formation
DK1641818T3 (da) Polypeptider der har bindingsaffinitet for HER2
Shim et al. Proposed systematic nomenclature for orbitides
Völkel et al. Interaction proteomics: characterization of protein complexes using tandem affinity purification–mass spectrometry
Boschetti et al. Low-abundance proteome discovery: state of the art and protocols
Padula et al. A comprehensive guide for performing sample preparation and top-down protein analysis
WO2004033631A8 (en) Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
Chong et al. Identification and Characterization of the Sulfolobus s olfataricus P2 Proteome
DE60234131D1 (de) Neue fusionsproteine und molekulare bindungsassays
Righetti Capillary electrophoretic analysis of proteins and peptides of biomedical and pharmacological interest
EA200400312A1 (ru) АНТАГОНИСТИЧЕСКИЕ АНТИТЕЛА ПРОТИВ hTNFSF13b ЧЕЛОВЕКА
WO2004024750A3 (en) Cd44-binding ligands
Righetti Real and imaginary artefacts in proteome analysis via two-dimensional maps
Wilkins et al. Proteome research: concepts, technology and application
WO2002080649A3 (en) Methods and systems for searching genomic databases
SE0301936D0 (sv) New polypeptide
DK1576157T3 (da) Fluorescerende proteiner fra Copepode-arter og fremgangsmåder til anvendelse af samme
WO2007058267A8 (ja) 新規タンパク質及びそれをコードする遺伝子
WO2006089801A3 (de) Verfahren zum redox-potential-abhängigen nachweis von targetmolekülen durch wechselwirkende polypeptide
WO2003070768A3 (en) Cd40 splice variants,method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof
Gilbert et al. Purification of fibrinogen and virus removal using preparative electrophoresis